NasdaqCM:ESTAMedical Equipment
Is Strong 2025 Performance And China Expansion Reframing The Investment Case For Establishment Labs (ESTA)?
Establishment Labs Holdings recently reported strong 2025 operating performance, highlighting rapid adoption of its Motiva implant platform, progress with next‑generation Preservé and Mia procedures, and new international partnerships including China under the leadership of CEO Peter Caldini.
This combination of product innovation and efforts to streamline global distribution, particularly in a large regulatory market like China, could materially influence the company’s long-term growth...